Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

IMQ backs Hong Kong based volatility arbitrage fund, True Partner

Tuesday, September 17, 2013

amb
Ralph van Put
Beverly Chandler, Opalesque London for New Managers:

Emerging manager specialist, IMQ, has invested $33m of 'acceleration capital’ to Asian volatility arbitrage expert, True Partner Fund. The investment takes the manager to assets under management of $107m.

Located in Hong Kong, the True Partner team is run by Ralph van Put and uses a sophisticated approach to volatility trading, combining broad options expertise, global trading experience, and advanced technology. While the focus rests on trading opportunities within the Asian markets, the team runs a truly global book.

The investment strategy can be characterised as medium frequency, market neutral trading and continuous hedging of volatility spread positions in listed options, predominantly in the equity index space. Emphasis is placed in pro-actively managing portfolio risks, through both static and scenario based risk analyses.

True Partner's Van Put commented on the investment, saying: "We are pleased with the cooperation with IMQ as it highlights our momentum in asset gathering, with IMQ providing an opportune bridgehead towards institutional investors".

IMQ’s CEO and Founder, Jeroen Tielman, comments: "We like the True Partner strategy as it has a strong track record of two years and it has a very low correlation to both hedge funds and conventional asset classes. T......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its